Home J&J buys bowel drug license option from Isis Pharma for $835 million
 

Keywords :   


J&J buys bowel drug license option from Isis Pharma for $835 million

2015-01-06 03:00:04| Food - Topix.net

Johnson & Johnson will pay Isis Pharmaceuticals Inc up to $835 million for the option to license three drugs targeting autoimmune diseases in the bowel. Isis Pharmaceuticals said it will receive $35 million in an upfront payment and will be eligible to receive royalties on sales of the drugs.

Tags: million license option drug

Category:Food and Related Products

Latest from this category

All news

»
01.07Union expected to call off Port Talbot strike action
01.07Mentorship in Motion
01.07Farm Progress America, July 1, 2024
01.07Hurricane Beryl Forecast Discussion Number 11
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Wind Speed Probabilities Number 11
01.07Hurricane Beryl Forecast Advisory Number 11
01.07Hurricane Beryl Public Advisory Number 11
More »